Navigation Links
Ganeden Biotech Teams Up with Connell Brothers to Take On Food Ingredients Asia 2013
Date:9/4/2013

Cleveland, OH (PRWEB) September 04, 2013

As they expand their presence in Asia, Ganeden Biotech, in partnership with their new distribution partner, Connell Brothers, will be exhibiting at the Food Ingredients Asia tradeshow at the International Trade and Exhibition Center (BITEC) in Bangkok, Thailand on September 11-13, 2013.

“We are aggressively expanding into the Asian market and it is very exciting to be exhibiting at our first Asian tradeshow,” said Michael Bush, VP of Business Development. “The Southeast-Asian food and beverage industry is growing very rapidly; so, being able to exhibit in conjunction with our distribution partner Connell Brothers is a great way for us to increase awareness of GanedenBC30.”

Connell Brothers and Ganeden Biotech cemented their partnership in April of 2013, with Connell Brothers being the exclusive distributor of GanedenBC30 throughout Southeast and North Asia. Operating in 17 countries throughout Asia-Pacific, Connell Brothers sustains a strong presence with 37 offices and multiple warehouses spread across the region.

Food Ingredients Asia is one of the largest food and beverage industry tradeshows in the world. With a growth of 25% annually over the last four years, and over eleven thousand visitors from 56 different countries; it continues to be a key course when entering the ASEAN (Association of Southeast Asian Nations) food and beverage industry.

To learn more about GanedenBC30 and its flexible formulation options, visit booth B-1. On hand will be examples of the many popular products enriched with GanedenBC30 and Stephen Quinn, Ganeden Biotech’s International Business Development and Regulatory Manager will be available to answer any questions you may have.

###

About GanedenBC30
Ganeden Biotech’s probiotic, GanedenBC30 (Bacillus coagulans GBI-30, 6086), is a patented, organism that can be found in more than 80 leading food, beverage and companion animal products throughout the world. Unlike most other probiotic strains used in food and beverages, GanedenBC30 is highly stable and can remain viable through processing, shelf life and the low pH of stomach acid. The efficacy of GanedenBC30 is backed by 17 published studies. GanedenBC30 has an exceptional safety record and FDA GRAS status from the United States Food and Drug Administration. For more information, please visit GanedenBC30.com.

About Connell Brothers
Connell Brothers is a division of Wilbur-Ellis Company and is the largest marketer and distributor of specialty chemicals and industrial ingredients in Asia-Pacific. With over 100 years in Asia and a keen focus on technical service, customer support and quality control, Connell Brothers provides complete supply chain management from transportation, documentation, warehousing, and sales and distribution in 17 countries and in 37 offices located throughout Asia-Pacific. For more information, please visit WilburEllis.com

About Ganeden Biotech
Ganeden Biotech is at the forefront of probiotic research and product development with an extensive library of published studies and more than 100 patents for probiotic technologies in the food, beverage, animal health, and now personal care ingredients markets. Ganeden is best known for GanedenBC30® (Bacillus coagulans GBI-30, 6086), its patented, FDA GRAS, highly stable probiotic ingredient. Ganeden's newest ingredient, Bonicel, is the first science-backed, probiotic-derived, personal care ingredient shown to dramatically reduce signs of aging. For more information about Ganeden Biotech and licensing opportunities visit GanedenBiotech.com.

Read the full story at http://www.prweb.com/releases/2013/9/prweb11087839.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Probiotic-Enriched Instant Chai Latte and Teas to be Launched by Ganeden Biotech and Tipton Mills
2. Ganeden Biotech Hires New Marketing Manager
3. Ganeden Biotech® Moves Its State-Of-The-Art Lab To Its World Headquarters In Cleveland
4. Ganeden Partner Product Wins SupplySide Insights Award
5. GenWay Biotech Launches New Cardiovascular Diagnostic Blood Test at American Heart Association Scientific Sessions 2011
6. Puma Biotechnology Announces Completion of Private Placement
7. Animal Biotechnology - Technologies, Markets and Companies
8. AtheroNova and Maxwell Biotech Group Ratify Agreement to Develop New Atherosclerosis Drug
9. The European Union Signs Grant Contract to Fund a 2 Million Euro Biotechnology Research Project Led by Hadassah College Jerusalem
10. Janssen Biotech, Inc. Announces Collaborative Development and Worldwide License Agreement for Investigational Anti-Cancer Drug, PCI-32765
11. Puma Biotechnology Announces Positive PB272 (Neratinib) Phase II Data at CTRC-AACR San Antonio Breast Cancer Symposium
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/16/2017)... February 16, 2017 Patient ... of innovative telemedicine application, new and leading edge ... experiencing a boom worldwide. The healthcare sector as ... technologies, services and new therapies for companies such ... RHT), Cellectar Biosciences, Inc. (NASDAQ: CLRB ...
(Date:2/16/2017)... SAN DIEGO , Feb. 16, 2017 /PRNewswire/ ... and innovative products to treat a variety of ... $5 million Series 1a financing and entered into ... Bank (SVB).  Dermata intends to use the capital ... of making major advancements in the treatment of ...
(Date:2/16/2017)... (PRWEB) , ... February 16, 2017 , ... ... cervical case. Dr. Kingsley Chin, professor and Harvard trained surgeon, completed the procedure ... was performed on a 55-year-old practicing female physician suffering from degenerative disc disease ...
(Date:2/16/2017)... BOSTON , Feb. 16, 2017 /PRNewswire/ ... for rare genetic deficiencies that result in ... of a $41 million mezzanine round of ... Ipsen, OrbiMed, MPM Capital, New Enterprise Associates, ... an undisclosed public healthcare investment fund. Rhythm ...
Breaking Biology Technology:
(Date:2/8/2017)... 2017 Report Highlights ... The global synthetic-biology market reached nearly ... 2021, growing at a compound annual growth rate (CAGR) of ... the global markets for synthetic biology. - Analyses of global ... projections of compound annual growth rates (CAGRs) through 2021. - ...
(Date:2/7/2017)... York , February 7, 2017 ... ID Global Solutions Corporation [OTC: IDGS], ("Ipsidy" or the ... and electronic transaction processing services, is pleased to announce ... the Company. Effective January 31, 2017, ... Board of Directors, CEO and President.  An experienced payment ...
(Date:2/2/2017)... , Feb. 2, 2017  EyeLock LLC, a market ... new white paper " What You Should Know About ... of ensuring user authenticity is a growing concern. In ... of users. However, traditional authentication schemes such as username/password ... Biometric authentication offers an elegant solution to the ...
Breaking Biology News(10 mins):